Titre : Cellules endothéliales

Cellules endothéliales : Questions médicales fréquentes

Termes MeSH sélectionnés :

Neurologic Examination
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cellules endothéliales : Questions médicales les plus fréquentes", "headline": "Cellules endothéliales : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cellules endothéliales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-18", "dateModified": "2025-04-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cellules endothéliales" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cellules épithéliales", "url": "https://questionsmedicales.fr/mesh/D004847", "about": { "@type": "MedicalCondition", "name": "Cellules épithéliales", "code": { "@type": "MedicalCode", "code": "D004847", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.436" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Progéniteurs endothéliaux", "alternateName": "Endothelial Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D066026", "about": { "@type": "MedicalCondition", "name": "Progéniteurs endothéliaux", "code": { "@type": "MedicalCode", "code": "D066026", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.436.275.182" } } }, { "@type": "MedicalWebPage", "name": "Cellules endothéliales de la veine ombilicale humaine", "alternateName": "Human Umbilical Vein Endothelial Cells", "url": "https://questionsmedicales.fr/mesh/D061307", "about": { "@type": "MedicalCondition", "name": "Cellules endothéliales de la veine ombilicale humaine", "code": { "@type": "MedicalCode", "code": "D061307", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.436.275.682" } } }, { "@type": "MedicalWebPage", "name": "Podosomes", "alternateName": "Podosomes", "url": "https://questionsmedicales.fr/mesh/D000069261", "about": { "@type": "MedicalCondition", "name": "Podosomes", "code": { "@type": "MedicalCode", "code": "D000069261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.436.275.841" } } } ], "about": { "@type": "MedicalCondition", "name": "Cellules endothéliales", "alternateName": "Endothelial Cells", "code": { "@type": "MedicalCode", "code": "D042783", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Peter Carmeliet", "url": "https://questionsmedicales.fr/author/Peter%20Carmeliet", "affiliation": { "@type": "Organization", "name": "Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium. peter.carmeliet@kuleuven.vib.be." } }, { "@type": "Person", "name": "Kim D Falkenberg", "url": "https://questionsmedicales.fr/author/Kim%20D%20Falkenberg", "affiliation": { "@type": "Organization", "name": "Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium." } }, { "@type": "Person", "name": "Katerina Rohlenova", "url": "https://questionsmedicales.fr/author/Katerina%20Rohlenova", "affiliation": { "@type": "Organization", "name": "Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium." } }, { "@type": "Person", "name": "Yonglun Luo", "url": "https://questionsmedicales.fr/author/Yonglun%20Luo", "affiliation": { "@type": "Organization", "name": "Lars Bolund Institute of Regenerative Medicine, BGI-Qindao, Qindao, China." } }, { "@type": "Person", "name": "Walter Muranyi", "url": "https://questionsmedicales.fr/author/Walter%20Muranyi", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, 68167, Mannheim, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "André-Thomas (1867-1963), Initiator of Neonatal Neurology.", "datePublished": "2023-09-01", "url": "https://questionsmedicales.fr/article/37660693", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000531863" } }, { "@type": "ScholarlyArticle", "name": "Neurological outcomes in neonates treated with therapeutic hypothermia: challenges in a developing country.", "datePublished": "2024-09-28", "url": "https://questionsmedicales.fr/article/39341210", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/s-0044-1790575" } }, { "@type": "ScholarlyArticle", "name": "Neurological soft signs are increased in migraine without aura: relationship with the affective status.", "datePublished": "2022-05-18", "url": "https://questionsmedicales.fr/article/35585436", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10072-022-06143-3" } }, { "@type": "ScholarlyArticle", "name": "The International Standards for Neurological Classification of Spinal Cord Injury: Classification Accuracy and Challenges.", "datePublished": "2023-02-15", "url": "https://questionsmedicales.fr/article/36819931", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.46292/sci22-00036" } }, { "@type": "ScholarlyArticle", "name": "eHealth tools to assess neurological function: a systematic review protocol for a mapping exercise.", "datePublished": "2022-09-26", "url": "https://questionsmedicales.fr/article/36167388", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2022-062691" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Cellules épithéliales", "item": "https://questionsmedicales.fr/mesh/D004847" }, { "@type": "ListItem", "position": 4, "name": "Cellules endothéliales", "item": "https://questionsmedicales.fr/mesh/D042783" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cellules endothéliales - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cellules endothéliales", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cellules endothéliales", "description": "Comment diagnostiquer une dysfonction endothéliale ?\nQuels examens pour évaluer les cellules endothéliales ?\nQuels marqueurs biologiques indiquent une inflammation endothéliale ?\nComment évaluer la perméabilité endothéliale ?\nQuels tests pour détecter des lésions endothéliales ?", "url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Neurologic+Examination&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cellules endothéliales", "description": "Quels symptômes indiquent une dysfonction endothéliale ?\nComment reconnaître une inflammation endothéliale ?\nQuels signes cliniques d'athérosclérose ?\nQuels symptômes d'une thrombose veineuse ?\nComment se manifeste une ischémie ?", "url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Neurologic+Examination&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cellules endothéliales", "description": "Comment prévenir la dysfonction endothéliale ?\nQuelles habitudes pour réduire l'inflammation ?\nComment prévenir l'athérosclérose ?\nQuelles mesures pour éviter la thrombose ?\nComment réduire le risque d'ischémie ?", "url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Neurologic+Examination&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cellules endothéliales", "description": "Quels traitements pour la dysfonction endothéliale ?\nComment traiter l'inflammation endothéliale ?\nQuelles interventions pour l'athérosclérose ?\nQuels médicaments pour prévenir la thrombose ?\nComment gérer l'ischémie chronique ?", "url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Neurologic+Examination&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cellules endothéliales", "description": "Quelles complications de la dysfonction endothéliale ?\nQuels risques liés à l'inflammation endothéliale ?\nQuelles complications de l'athérosclérose ?\nQuels dangers d'une thrombose veineuse ?\nQuelles complications de l'ischémie ?", "url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Neurologic+Examination&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cellules endothéliales", "description": "Quels facteurs de risque pour la dysfonction endothéliale ?\nComment le stress influence-t-il l'endothélium ?\nQuels rôles du cholestérol dans la santé endothéliale ?\nComment l'alimentation affecte-t-elle l'endothélium ?\nQuels impacts de l'inactivité physique sur l'endothélium ?", "url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Neurologic+Examination&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction endothéliale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'échographie Doppler et les marqueurs sanguins peuvent être utilisés." } }, { "@type": "Question", "name": "Quels examens pour évaluer les cellules endothéliales ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les biopsies tissulaires et les analyses histologiques sont couramment pratiquées." } }, { "@type": "Question", "name": "Quels marqueurs biologiques indiquent une inflammation endothéliale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme la protéine C-réactive et les cytokines peuvent être mesurés." } }, { "@type": "Question", "name": "Comment évaluer la perméabilité endothéliale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de perméabilité utilisant des colorants ou des marqueurs radioactifs sont effectués." } }, { "@type": "Question", "name": "Quels tests pour détecter des lésions endothéliales ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'angiographie et l'imagerie par résonance magnétique peuvent révéler des lésions." } }, { "@type": "Question", "name": "Quels symptômes indiquent une dysfonction endothéliale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs thoraciques, des troubles circulatoires et des œdèmes peuvent survenir." } }, { "@type": "Question", "name": "Comment reconnaître une inflammation endothéliale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, chaleur et gonflement au site affecté sont des signes d'inflammation." } }, { "@type": "Question", "name": "Quels signes cliniques d'athérosclérose ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Douleurs dans la poitrine, fatigue et essoufflement peuvent indiquer une athérosclérose." } }, { "@type": "Question", "name": "Quels symptômes d'une thrombose veineuse ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Gonflement, douleur et rougeur dans la zone touchée sont des symptômes courants." } }, { "@type": "Question", "name": "Comment se manifeste une ischémie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "L'ischémie se manifeste par des douleurs, des engourdissements et une faiblesse musculaire." } }, { "@type": "Question", "name": "Comment prévenir la dysfonction endothéliale ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est essentiel." } }, { "@type": "Question", "name": "Quelles habitudes pour réduire l'inflammation ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabac, réduire le stress et consommer des aliments anti-inflammatoires aide." } }, { "@type": "Question", "name": "Comment prévenir l'athérosclérose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Contrôler la pression artérielle, le cholestérol et pratiquer une activité physique régulière." } }, { "@type": "Question", "name": "Quelles mesures pour éviter la thrombose ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Rester actif, s'hydrater et éviter de rester immobile longtemps sont des mesures préventives." } }, { "@type": "Question", "name": "Comment réduire le risque d'ischémie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Gérer le diabète, contrôler le poids et éviter les aliments riches en graisses saturées." } }, { "@type": "Question", "name": "Quels traitements pour la dysfonction endothéliale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les statines et des changements de mode de vie sont recommandés." } }, { "@type": "Question", "name": "Comment traiter l'inflammation endothéliale ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des anti-inflammatoires et des corticostéroïdes peuvent être prescrits selon la gravité." } }, { "@type": "Question", "name": "Quelles interventions pour l'athérosclérose ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des procédures comme l'angioplastie ou le pontage peuvent être nécessaires." } }, { "@type": "Question", "name": "Quels médicaments pour prévenir la thrombose ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les anticoagulants et les antiplaquettaires sont souvent utilisés pour prévenir la thrombose." } }, { "@type": "Question", "name": "Comment gérer l'ischémie chronique ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements médicaux, des exercices et parfois une chirurgie sont envisagés." } }, { "@type": "Question", "name": "Quelles complications de la dysfonction endothéliale ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des maladies cardiovasculaires, des AVC et des troubles circulatoires." } }, { "@type": "Question", "name": "Quels risques liés à l'inflammation endothéliale ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "L'inflammation peut provoquer des thromboses, des embolies et des maladies auto-immunes." } }, { "@type": "Question", "name": "Quelles complications de l'athérosclérose ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut mener à des crises cardiaques, des AVC et des douleurs angineuses." } }, { "@type": "Question", "name": "Quels dangers d'une thrombose veineuse ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une thrombose peut provoquer une embolie pulmonaire, mettant en danger la vie." } }, { "@type": "Question", "name": "Quelles complications de l'ischémie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "L'ischémie peut entraîner des lésions tissulaires, des gangrènes et des amputations." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la dysfonction endothéliale ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'hypertension, le diabète, le tabagisme et l'obésité augmentent le risque." } }, { "@type": "Question", "name": "Comment le stress influence-t-il l'endothélium ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut aggraver l'inflammation et la dysfonction endothéliale." } }, { "@type": "Question", "name": "Quels rôles du cholestérol dans la santé endothéliale ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un taux élevé de cholestérol LDL est un facteur de risque majeur pour les maladies vasculaires." } }, { "@type": "Question", "name": "Comment l'alimentation affecte-t-elle l'endothélium ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en graisses saturées et en sucres peut nuire à la fonction endothéliale." } }, { "@type": "Question", "name": "Quels impacts de l'inactivité physique sur l'endothélium ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le manque d'exercice physique contribue à la dysfonction endothéliale et aux maladies cardiovasculaires." } } ] } ] }

Sources (10000 au total)

Neurological outcomes in neonates treated with therapeutic hypothermia: challenges in a developing country.

Hypoxic-ischemic encephalopathy (HIE) affects 1.5 newborns per 1 thousand term live births. Therapeutic hypothermia (TH) does not prevent all adverse outcomes. The experience with TH is still limited ... To describe the frequency of epilepsy, altered neurological exam, and neurodevelopmental delay at 12 months of age in patients treated with TH in a reference hospital in Rio de Janeiro and to evaluate... We evaluated medical records from the Neonatal Intensive Care Unit hospitalization and from first evaluation recorded at 12 months of age in the High-Risk Neonate Follow-up Outpatient Sevice.... A total of 30 subjects were included in the study. We found epilepsy in 18.2% of the patients, altered neurological exam in 40.9%, and neurodevelopmental delay in 36.4%. We also found a significant re... High incidences of epilepsy, altered neurological exams, and neurodevelopmental delay were found, despite the use of TH. A more efficient use of resources is needed, as well as measures such as early ...

Neurological soft signs are increased in migraine without aura: relationship with the affective status.

Neurological soft signs (NSS) are subtle non-localizing sensorimotor abnormalities initially reported as increased in primary headache patients. The aims of this study were confirming with full power ... Forty drug-free episodic migraine outpatients (MH) were recruited with 40 matched controls. NSS were determined by the 16-item Heidelberg scale; depression, anxiety and QoL by the HAM-D; the STAI-X1/X... NSS were 46% increased in MH vs. controls (p = 0.0001). HAM-D and STAI-X1/X2 were increased in MH, while SF36 was unchanged, but they all failed to influence NSS, just as MH characteristics. NSS score... NSS are increased in MH and probably not influenced by the affective status, possibly marking a dysfunction within the cerebellar-thalamic-prefrontal circuit that may deserve further attention from th...

The International Standards for Neurological Classification of Spinal Cord Injury: Classification Accuracy and Challenges.

Successful utilization of the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) requires a comprehensive understanding of its rules, terminology, and several comp... To evaluate classification accuracy of SCI professionals using the 2019 ISNCSCI edition, identify common mistakes and areas of confusion, and assess associations between experience in ISNCSCI classifi... Members of the International Spinal Cord Society (ISCoS) and attendees of the ISCoS Annual Scientific Meeting 2021 were invited to complete an online survey that included six ISNCSCI cases to classify... A total of 107 persons completed the survey, with overall classification accuracy of 74.6%. Accuracy was highest for injury completeness (95.3%) and sensory level (91.1%) and lowest for motor zone of ... Classification accuracy of an international cohort of SCI professionals was modest but greater than previous reports. Knowledge deficits about the 2019 ISNCSCI updates are prevalent and contribute to ...

eHealth tools to assess neurological function: a systematic review protocol for a mapping exercise.

Population-based epidemiological studies investigating risk/protective factors are outlining prevention strategies for neurological conditions that often do not have effective treatment. However, asce... We propose a systematic review mapping the available eHealth tools for assessing the different aspects of neurological function. The search aims at identifying studies published in peer-reviewed journ... This mapping exercise will be made available to researchers in order to aid them in successfully ascertaining neurological outcomes in large population-based epidemiological studies. Given the nature ...

Computer International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) algorithms: a review.

Literature review and survey.... To provide an overview of existing computerized International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) algorithms and to evaluate the use of the current algorithms in ... Not applicable.... Literature review according to three organizing concepts for evaluation of Health Information Products (reach, usefulness, and use) was conducted.... While the use of computerized ISNCSCI algorithms has been around for many years, many were developed and used internally for specific projects or not maintained. Today the International SCI community ... Validated computerized ISNCSCI classification tools have evolved substantially and support education, clinical documentation, communication between clinicians and their patients, and ISNCSCI data qual...

Neurological soft signs are associated with reduced medial-lateral postural control in adolescent athletes.

Neurological soft signs (NSS) are minor deviations from the norm in motor performance that are commonly assessed using neurological examinations. NSS may be of clinical relevance for evaluating the de... Male adolescent athletes (n = 141) aged 13-16 years from three European sites underwent a neurological examination including 28 tests grouped into six functional clusters. The performance of tests and... There was no significant overall difference between the NSS+ and NSS- group in postural control. However, non-optimal performing participants in the diadochokinesis test swayed significantly more in t... Our findings demonstrate that NSS are related to postural control in adolescent athletes. Thus, force plate measures may add a quantitative, objective measurement of postural control to observer-based...

Neurological symptoms after COVID-19 vaccination: a report on the clinical presentation of the first 50 patients.

Neurological symptoms associated with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) vaccination were discovered in the context of billions of administered vaccine doses. The clinical ma... We assessed routine clinical examinations in 50 patients reporting new-onset neurological symptoms after SARS-CoV-2 vaccination, including neurological examination, laboratory and electrophysiology te... The most frequently reported symptoms were paraesthesia (56%), fatigue (46%) and cognitive impairment (36%). Neurological, routine laboratory, and electrophysiological examinations did not yield disti... The spectrum of clinical manifestations post-vaccination poses a substantial overlap with PCS symptoms. As no pathological findings were obtained in routine diagnostics, uncertainty remains about the ...

A pilot examination of the validity of stylus and finger drawing on visuomotor-mediated tests on ACEmobile.

Cognitive assessments, such as the Addenbrooke's Cognitive Examination (ACE-III) and Montreal Cognitive Assessment (MoCA), have been modified for administration using tablet computers. While this offe... This study recruited 26 participants with Alzheimer's disease and 23 healthy older adults. Most participants had low familiarity with using a tablet computer. Participants completed ACEmobile in its e... Statistically significant differences were observed between the finger and pencil administration on the ACEmobile, with participants performing worse on the finger drawing trials. Differences in score... The findings of this pilot study have important implications for clinical neuropsychology and demonstrate that administering ACEmobile drawing tests with finger drawing is invalid. However, due to the...